Introducción Mi relación con la sustitución hormonal ha sido larga y fructífera. Yo fui diagnosticado con testosterona baja en 1993, a la edad de 34, luego de haber estado viviendo con VIH por 11 años. Yo había perdido 14 libras (6,35 Kg) involuntariamente, me sentía cansado y deprimido, y no tenía deseo sexual en lo …
IAC Summary on New Drugs and New Combinations – How will They Change What We Do? Vienna July 18-23 2010 Joe Eron, Univ of North Carolina This year’s IAC was one of the most exciting and data-filled International AIDS meetings since Vancouver in 1996. The defining presentation of the meeting was the CAPRISA 004 study that …
New Drugs and New Combinations – How will They Change What We Do? Read More »
This report reviews the status of research of drugs for HIV, TB, Hepatis C, immune based therapies. https://i-base.info/files/2010/06/2010-pipeline-webFINAL.pdf
What am I going to do now, Nelson? Aug 6, 2010 Hi Nelson, I hope all is well. Last year you told me about the trial with ibalizumab at ACRIA and I received the meds for about 1 year. In the beginning of thet trial the virus became undectadable but then it started to go …
My Web page on amazon.com showing all my books in print and kindle versions. https://www.amazon.com/-/e/B003E3RYKY My book: Testosterone: A Man’s Guide is up as of today! I hope everyone enjoys it. Nelson
I am excited to have been invited to speak at the International AIDS Conference in Vienna in two weeks This is my workshop https://pag.aids2010.org/session.aspx?s=419 https://pag.aids2010.org/PAGHome.aspx?pid=53000
Wellcare put together a great summary of all codes used for reimbursement. Medicare decided in January 2010 to cover HIV facial lipoatrophy products as long as the patient has depression induced by this condition. https://www.wellcare.com/WCAssets/corporate/assets/HS134_Dermal_Injections_for_Facial_Lipodystrophy_Syndrome.pdf
This company is seeking to get approval of a drug protocol that will speed up the normalization of the Hypothalamus-Pituitary-Gonadal (HPG) Axis after long term use of anabolic steroids or testosterone for medical or non medical uses. Cessation of anabolics or testosterone replacement causes androgen -induced hypogonadism that can negatively impact someone’s health if the …
Pipeline Problems by David Evans In the past month, two companies shelved their once-promising experimental HIV drugs, citing the challenging nature of bringing a profitable product to market. Has the overwhelming success of modern-day HIV drugs jeopardized the future of new HIV treatment options? Since Matt Sharp first learned that he was HIV positive in …
June 17, 2010 Dr. Susan Cox Former Senior Vice President, Drug Development at Avexa Cc: Nathan Drona, Chairman of the Board at Avexa Stephen Kerr, Board Secretary We, the undersigned, are asking the decision makers at Avexa to reconsider the decision to stop the development of apricitabine, a nucleoside analog that has shown good efficacy in …
AIDS activists ask AVEXA not to leave patients behind Read More »
I am scared that companies are dropping new HIV medications Jun 17, 2010 Nelson, I emailed you before and you told me there were a few medications in research for people with resistance to all meds. But I just heard that two companies abandoned their research. What does that mean for someone like me who …
HIV Salvage Patients Are Concerned About Recent Pharma Decisions Read More »
